Miriam de Groote

628 citations

13 papers · 565 indexed · h-index 12

Co-authors: Adriaan P. IJzerman Jacqueline E. van Muijlwijk‐Koezen Erica W. van Tilburg Wiro M. P. B. Menge Roeland C. Vollinga H. Timmerman Henk Timmerman H. van der Goot
Topics: Adenosine and Purinergic Signaling (13 papers)Synthesis and Biological Evaluation (8 papers)Pharmacological Receptor Mechanisms and Effects (4 papers)
Cited by: Physiology Organic Chemistry Cellular and Molecular Neuroscience
Journals: Journal of Medicinal Chemistry Biochemical Pharmacology Bioorganic & Medicinal Chemistry
Partner nations: Netherlands Germany Greece

In The Last Decade

Miriam de Groote

13 papers receiving 551 citations

Peers

Countries citing papers authored by Miriam de Groote

Since Specialization

Citations

This map shows the geographic impact of Miriam de Groote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam de Groote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam de Groote more than expected).

Fields of papers citing papers by Miriam de Groote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam de Groote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam de Groote. The network helps show where Miriam de Groote may publish in the future.

Co-authorship network of co-authors of Miriam de Groote

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam de Groote. A scholar is included among the top collaborators of Miriam de Groote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam de Groote. Miriam de Groote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor 2003 ·Bioorganic & Medicinal Chemistry ·Erica W. van Tilburg,(unknown),(unknown),Miriam de Groote,Adriaan P. IJzerman	29
2	Modulation of agonist responses at the A1 adenosine receptor by an irreversible antagonist, receptor–G protein uncoupling and by the G protein activation state 2002 ·Biochemical Pharmacology ·Anna Lorenzen,Margot W. Beukers,(unknown),(unknown),Jacqueline E. van Muijlwijk‐Koezen,Miriam de Groote,Wiro M. P. B. Menge,Ulrich Schwabe,Adriaan P. IJzerman	14
3	Substituted 4-Phenyl-2-(phenylcarboxamido)-1,3-thiazole Derivatives as Antagonists for the Adenosine A1 Receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·Erica W. van Tilburg,P. A. M. VAN DER KLEIN,Miriam de Groote,(unknown),Adriaan P. IJzerman	30
4	Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor11Abbreviations: CCPA, 2-chloro-N6-cyclopentyladenosine; DPCPX, 1,3-dipropyl-8-cyclopentylxanthine; CPA, N6-cyclopentyladenosine, R-PIA, N6-[-(R)-1-methyl-2-phenylethyl]adenosine; NECA, 5′-(N-ethyl)-carboxamidoadenosine; N-0840, N6-cyclopentyl-9-methyladenine; theophylline, 1,3-dimethylxanthine; PD81,723, (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone; BCA, bicinchoninic acid; BCS, bovine calf serum; cAMP, adenosine 3′,5′-cyclic monophosphate; DMEM, Dulbecco’s modified Eagle’s medium; CHO, Chinese hamster ovary; and wt, wild-type. 2001 ·Biochemical Pharmacology ·Angeliki P. Kourounakis,Corine C. Visser,Miriam de Groote,Adriaan P. IJzerman	46
5	2,5‘-Disubstituted Adenosine Derivatives: Evaluation of Selectivity and Efficacy for the Adenosine A₁, A_2A, and A₃ Receptor 2001 ·Journal of Medicinal Chemistry ·Erica W. van Tilburg,(unknown),Miriam de Groote,Adriaan P. IJzerman	40
6	Synthesis and use of FSCPX, an irreversible adenosine A1 antagonist, as a ‘Receptor Knock-Down’ tool 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jacqueline E. van Muijlwijk‐Koezen,Henk Timmerman,(unknown),(unknown),Wiro M. P. B. Menge,Margot W. Beukers,Piet H. van der Graaf,Miriam de Groote,Adriaan P. IJzerman	20
7	5‘-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives: Partial Agonists for the Adenosine A₁ and A₃ Receptors 2001 ·Journal of Medicinal Chemistry ·Erica W. van Tilburg,(unknown),(unknown),Miriam de Groote,(unknown),Anna Lorenzen,Adriaan P. IJzerman	40
8	Thiazole and Thiadiazole Analogues as a Novel Class of Adenosine Receptor Antagonists 2001 ·Journal of Medicinal Chemistry ·Jacqueline E. van Muijlwijk‐Koezen,H. Timmerman,Roeland C. Vollinga,(unknown),Miriam de Groote,(unknown),Adriaan P. IJzerman	128
9	Allosteric modulation of the rat adenosine A₁ receptor: Differential effects on agonist and antagonist binding 2000 ·Drug Development Research ·Angeliki P. Kourounakis,Corine C. Visser,Miriam de Groote,Adriaan P. IJzerman	7
10	Isoquinoline and Quinazoline Urea Analogues as Antagonists for the Human Adenosine A₃Receptor 2000 ·Journal of Medicinal Chemistry ·Jacqueline E. van Muijlwijk‐Koezen,Henk Timmerman,H. van der Goot,Wiro M. P. B. Menge,(unknown),Miriam de Groote,Adriaan P. IJzerman	106
11	Phenyl-substituted N6-phenyladenosines and N6-phenyl-5?-N-ethylcarboxamidoadenosines with high activity at human adenosine A2B receptors 2000 ·Drug Development Research ·(unknown),Miriam de Groote,(unknown),(unknown),(unknown),(unknown),Adriaan P. IJzerman	16
12	N⁶,5‘-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A₃ Receptor 1999 ·Journal of Medicinal Chemistry ·Erica W. van Tilburg,(unknown),Miriam de Groote,(unknown),Anna Lorenzen,Adriaan P. IJzerman	37
13	Potent antagonists for the human adenosine A2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity 1999 ·Drug Development Research ·(unknown),(unknown),Margot W. Beukers,(unknown),(unknown),Miriam de Groote,Adriaan P. IJzerman	52

About Miriam de Groote

Miriam de Groote is a scholar working on Physiology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 13 papers that have together received 565 indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (13 papers), Synthesis and Biological Evaluation (8 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). The work is most often cited by research in Physiology (322 citations), Organic Chemistry (274 citations) and Cellular and Molecular Neuroscience (97 citations). Miriam de Groote has collaborated with scholars based in Netherlands, Germany and Greece. Frequent co-authors include Adriaan P. IJzerman, Jacqueline E. van Muijlwijk‐Koezen, Erica W. van Tilburg, Wiro M. P. B. Menge, Roeland C. Vollinga, H. Timmerman, Henk Timmerman, H. van der Goot, Anna Lorenzen and Angeliki P. Kourounakis. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact